Literature DB >> 8843054

Role of superoxide anions in airway hyperresponsiveness induced by cigarette smoke in conscious guinea pigs.

M Nishikawa1, M Kudo, N Kakemizu, H Ikeda, T Okubo.   

Abstract

To investigate the involvement of superoxide in airway hyperresponsiveness and bronchoconstriction induced by cigarette smoke (CS), we evaluated the effects of superoxide dismutase (SOD), a scavenger of superoxide anion, and apocynin, an inhibitor of superoxide anion-generating NADPH oxidase in phagocytes, on the airway responses induced by CS in conscious guinea pigs. Airway responsiveness was assessed by PC200Mch, the concentration required to produce a doubling in the baseline specific airway resistance (sRaw) to an inhaled methacholine aerosol, in nonanesthetized spontaneously breathing animals. Before being exposed to ten puffs of CS, animals inhaled either SOD (5,000 units/ml or 25,000 units/ml) or vehicle. Although SOD did not affect PC200Mch in the air control group, this agent significantly reduced the CS-induced airway hyperresponsiveness. Repeated administration of apocynin (12 mg/kg for 4 days) did not affect PC200Mch after exposure to CS. These data suggest that the superoxide from CS was involved in the airway hyperresponsiveness induced by CS, whereas phagocytic reactive oxygen species were not. The data also suggest a potential therapeutic role for antioxidants in airway hyperresponsiveness.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843054     DOI: 10.1007/bf00176187

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  31 in total

1.  Prostaglandin biosynthesis can be triggered by lipid peroxides.

Authors:  M E Hemler; H W Cook; W E Lands
Journal:  Arch Biochem Biophys       Date:  1979-04-01       Impact factor: 4.013

2.  Acute effects of inhalation of cigarette smoke on airway conductance.

Authors:  J A NADEL; J H COMROE
Journal:  J Appl Physiol       Date:  1961-07       Impact factor: 3.531

3.  Functional and metabolic properties of alveolar macrophages in response to the gas phase of tobacco smoke.

Authors:  D B Drath; J M Shorey; G L Huber
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

4.  Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils.

Authors:  J M Simons; B A Hart; T R Ip Vai Ching; H Van Dijk; R P Labadie
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

5.  Involvement of superoxide in ozone-induced airway hyperresponsiveness in anesthetized cats.

Authors:  T Takahashi; M Miura; U Katsumata; M Ichinose; K Kimura; H Inoue; T Takishima; K Shirato
Journal:  Am Rev Respir Dis       Date:  1993-07

6.  Mechanisms contributing to ozone-induced bronchial hyperreactivity in guinea-pigs.

Authors:  M Yeadon; D Wilkinson; V Darley-Usmar; V J O'Leary; A N Payne
Journal:  Pulm Pharmacol       Date:  1992

7.  Role of nitric oxide and superoxide anions in interleukin-1 beta-induced airway hyperresponsiveness to bradykinin.

Authors:  H Tsukagoshi; R A Robbins; P J Barnes; K F Chung
Journal:  Am J Respir Crit Care Med       Date:  1994-10       Impact factor: 21.405

8.  Lipid mediators contribute to oxygen-radical-induced airway responses in sheep.

Authors:  M W Lansing; E Mansour; A Ahmed; A Cortes; L Garcia; I T Lauredo; A Wanner; W M Abraham
Journal:  Am Rev Respir Dis       Date:  1991-12

9.  The effect of antioxidants on ozone-induced airway hyperresponsiveness in dogs.

Authors:  S Matsui; G L Jones; M J Woolley; C G Lane; L S Gontovnick; P M O'Byrne
Journal:  Am Rev Respir Dis       Date:  1991-12

10.  Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar.

Authors:  W A Pryor; D G Prier; D F Church
Journal:  Environ Health Perspect       Date:  1983-01       Impact factor: 9.031

View more
  1 in total

Review 1.  Apocynin: molecular aptitudes.

Authors:  J Stefanska; R Pawliczak
Journal:  Mediators Inflamm       Date:  2008-12-02       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.